News & Resources
October 8, 2020

Should You Reshore? Seven Considerations for US Production

Offshore Manufacturing Isn’t Necessarily the Best Strategy Anymore

In the age of global pandemics, tariffs, and volatile trade relations, Total Cost of Ownership (TCO) analysis is more crucial than ever for determining if reshoring ought to be considered. A TCO can help address intangibles such as opportunity costs and risk factors for both the current environment and as you plot your course for the years ahead.

Download our guide for seven important considerations to keep in mind as you evaluate the true value of your manufacturing strategy.

Get your free copy of our Reshoring Guide:

  • This field is for validation purposes and should be left unchanged.

About Baril Corporation

With a passion for helping those who help others, we’re honored to create and provide clients with medical products that change lives. Baril Corporation strives to set the industry standard as the premier end-to-end contract manufacturer for wound care, clinical chemistry, patient monitoring, medical and surgical single-use, and infection prevention products. With our US-based supply chain, rapid prototyping capabilities, deep engineering expertise, and available capacity, we can pivot quickly to meet market demand. Our scalability and nimbleness allows us to offer clients the range of services they need, from individual component production to in-house product development, packaging, and fulfillment.